3rd Quarter - Report

PUBLIC CITIZEN for PUBLIC CITIZEN

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

13 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Clean budget free from policy riders and with appropriate funding

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —

Contacted: Federal Communications Commission (FCC); Consumer Product Safety Commission (CPSC); Securities & Exchange Commission (SEC); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Trade (domestic/foreign) TRD

NAFTA renegotiation,

LobbyistCovered position, as disclosed
LORI WALLACH —

Contacted: Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Consumer Product Safety Commission (CPSC); Federal Communications Commission (FCC); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE

Civil Rights/Civil Liberties CIV

HR 1215-Protecting access to care act of 2017, CFPB arbitration rule, CMS arbitration rule, Civil justice issues,

LobbyistCovered position, as disclosed
REMINGTON GREGG —

Contacted: Consumer Product Safety Commission (CPSC); Federal Trade Commission (FTC); Federal Communications Commission (FCC); Securities & Exchange Commission (SEC); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 1215 (115th)

Pharmacy PHA

S 934/HR 2430-FDA re-authorization Act of 2017, S 974/HR 2212-CREATES Act, S 771/HR 1776-Improving access to affordable prescription drugs act, S 204-Trickett Wendler Right to try act of 2017, S 1509/HR 1223-OPEN act, S 1369/HR 2974-Stop Price Gouging Act, Preserve access to affordable generics act, HR 205-to amend the Food, Drug & Cosmetic Act to require labeling of genetically engineered fish, S 495-Medicaid Innovation Price Fund Act, S 252-Medicaid Drug Savings Act of 2017,S 1131/HR 2439-Fair Accountability and Innovative Research Drug Pricing Act of 2017, HR 1628-American Health Care Act of 2017, S 297-Increasing Competition in Pharmaceuticals Act, HR 749 Lower drugs through Competition act, S 1390-stronger patents act of 2017, S 168/HR 3536-A bill to require persons who undertake federally funded research and development of drugs to enter into reasonable pricing agreements with Secretary of HHS.

LobbyistCovered position, as disclosed
STEVEN KNIEVEL —

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Consumer Product Safety Commission (CPSC); SENATE; Federal Communications Commission (FCC); U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC)

Bills named: H.R. 1223 (115th), H.R. 3536 (115th), H.R. 1776 (115th), H.R. 2430 (115th), H.R. 2974 (115th), H.R. 749 (115th), H.R. 205 (115th), H.R. 2439 (115th), H.R. 2212 (115th), H.R. 1628 (115th)

Banking BAN

HR 790-Return to Prudent Banking Act of 2017, S 881-21st Century Glass Steagall Act of 2017, Executive compensation, House Appropriations financial services, General banking issues, Protecting Dodd-Frank, strong SEC rules on disclosure, support the shareholder protection act, removing forced arbitration clauses from banking contracts, Equifax

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
BARTLETT NAYLOR —

Contacted: U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Consumer Product Safety Commission (CPSC); Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES; Federal Communications Commission (FCC)

Bills named: H.R. 790 (115th)

Taxation/Internal Revenue Code TAX

S 82-Stop subsidizing multi-million dollar corporate bonuses Act, Support BLP legislation, Oppose Johnson Amendment repeal, Tax reform, Wall Street Speculation Tax/Financial Transaction tax, opposing tax breaks for the rich and corporations, H. Res. 479-tax returns of President Trump.

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
SUSAN ELAINE HARLEY —
BARTLETT NAYLOR —
EMILY PETERSON CASSIN —

Contacted: SENATE; Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Consumer Product Safety Commission (CPSC); HOUSE OF REPRESENTATIVES; Federal Communications Commission (FCC)

Bills named: H.Res. 479 (115th)

Consumer Issues/Safety/Products CSP

S.951-Regulatory Accountability Act, Regulatory reform, consumer protection issues, CPSC priorities hearing, class action notices, Robocalls,

LobbyistCovered position, as disclosed
REMINGTON GREGG —
AMIT NARANG —

Contacted: Securities & Exchange Commission (SEC); Consumer Product Safety Commission (CPSC); Federal Communications Commission (FCC); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Bills named: S. 951 (115th)

Labor Issues/Antitrust/Workplace LBR

General worker safety issues, safe patient handling, FY18 Labor HHS appropriations

LobbyistCovered position, as disclosed
EMILY GARDNER —

Contacted: Consumer Product Safety Commission (CPSC); Federal Communications Commission (FCC); Federal Trade Commission (FTC); SENATE; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Government Issues GOV

Strengthening/reform Office of Government Ethics, Reform Foreign Agents Registration Act (FARA), Strengthening the STOCK act, Conflict of Interest standard, Campaign Finance reform policies, We The People package, Advocating for a clear investigation into any Russia collusion or obstruction, support disclosure of Political spending,

LobbyistCovered position, as disclosed
LISA JEAN GILBERT —
SUSAN ELAINE HARLEY —
CRAIG HOLMAN —

Contacted: U.S. Trade Representative (USTR); Consumer Product Safety Commission (CPSC); Federal Trade Commission (FTC); SENATE; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Federal Communications Commission (FCC)

Law Enforcement/Crime/Criminal Justice LAW

Senator Reed Bill on pay and penalties

LobbyistCovered position, as disclosed
BARTLETT NAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Communications Commission (FCC); Federal Trade Commission (FTC); Consumer Product Safety Commission (CPSC); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR)

Health Issues HCR

Single Payer Health Care, S 934/HR 2430-FDA re-authorization Act of 2017, S 974/HR 2212-CREATES Act, S 771/HR 1776-Improving access to affordable prescription drugs act, S 204-Trickett Wendler Right to try act of 2017, S 1509/HR 1223-OPEN act, S 1369/HR 2974-Stop Price Gouging Act,

LobbyistCovered position, as disclosed
SHANNA DEVINE —
SUSAN ELAINE HARLEY —
EAGAN KEMP —

Contacted: Consumer Product Safety Commission (CPSC); Federal Communications Commission (FCC); Federal Trade Commission (FTC); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1223 (115th), H.R. 2974 (115th), H.R. 2430 (115th), H.R. 1776 (115th), H.R. 2212 (115th)

Accounting ACC

PCAOB rulemaking on audit

LobbyistCovered position, as disclosed
BARTLETT NAYLOR —

Contacted: Securities & Exchange Commission (SEC); Federal Communications Commission (FCC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Consumer Product Safety Commission (CPSC); SENATE

Financial Institutions/Investments/Securities FIN

Strengthening STOCK act, conflict of interest standard

LobbyistCovered position, as disclosed
CRAIG HOLMAN —

Contacted: Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); U.S. Trade Representative (USTR); SENATE; Consumer Product Safety Commission (CPSC); Federal Communications Commission (FCC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.